Medicare Advantage patients less likely to get pricier diabetes meds, study finds

(By Andrew Cass for Becker’s Hospital Review)

Diabetes patients’ Medicare Advantage plans were more likely to receive preventive treatments than those with fee-for-service Medicare plans and less likely to receive new, more expensive medications, according to a University of Pittsburgh Medical Center study. Continue reading here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org